Free Pathology CE/CME

Mastering Advances in Managing Unresectable and Metastatic NSCLC—Immunotherapy, Targeted Therapies, and Emerging Strategies

Marina Chiara Garassino, MD; Sarah Goldberg, MD, MPH; Biagio Ricciuti, MD, …

---

Advancing Outcomes in Limited-Stage Small Cell Lung Cancer: From Evidence to Practice

Lauren Averett Byers, MD; Percy Lee, MD, FASTRO; Erminia Massarelli, MD, Ph…

---

Virtual Testing Board: Digging Deeper on Your Testing Reports to Elevate Patient Outcomes in Advanced Non–Small Cell Lung Cancer

Stephen V. Liu, MD; Michelle Afkhami, MD; Ignacio I. Wistuba, MD; Helena Yu…

---

Show Me the Data™: Bridging Clinical Gaps Along the Continuum From Resectable, Early Stage to Advanced Gastric/Gastroesophageal Junction Cancers

Zev A. Wainberg, MD; Manish A. Shah, MD, FASCO; Syma Iqbal, MD

---

Tumor Board: Molecular Testing and Personalized Strategies in Pancreatic Cancer: Targeting NRG1 and Rare Drivers With an Optimized Approach

E. Gabriela Chiorean, MD, FASCO; Daniel H. Ahn, DO, MS; Benjamin A. Weinber…

---

Mastering Epithelioid Sarcoma: Enhancing Diagnostic Precision and Tailoring Treatment Strategies

Mark Agulnik, MD; Mrinal M. Gounder, MD; Jacqueline M. Kraveka, DO; Daniel …

---

Clinical Showcase™: Selecting the Best Next Steps for a Patient with Epithelioid Sarcoma

Mark Agulnik, MD; Daniel Lefler, MD

---

Oncology Consultations®: Epithelioid Sarcoma: Applying Clinical Updates to Real Patient Cases

Mark Agulnik, MD; Shaina A. Rozell, MD, MPH

---

Collaborating Across the Continuum®: Identifying and Treating Epithelioid Sarcoma

Mark Agulnik, MD; Mrinal M. Gounder, MD; Jacqueline M. Kraveka, DO; Lee M. …

---

Homing in on the Role of PSMA in Prostate Cancer – Harnessing the Power of Precision Medicine Through Imaging and Therapy to Individualize Treatment Plans

Mary-Ellen Taplin, MD; Jason A. Efstathiou, MD, DPhil, FASTRO, FACRO; Phill…

---

Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection

Charu Aggarwal, MD, MPH, FASCO; Christine Bestvina, MD; Hatim Husain, MD; K…

---

New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment

Megan E. Daly, MD; Nagla F. Abdel Karim, MD, PhD; Chul Kim, MD

---

Community Practice Connections™: Selecting and Sequencing Therapy for Patients with DLBCL in an Era of Expanding Options

Sarah C. Rutherford, MD; Matthew Lunning, DO, FACP

---

Advances In™: Moving Care Forward in SCLC with DLL3 Targeting Bispecific T-Cell Engagers

Jennifer Carlisle, MD; Martin Wermke, MD

---

Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?

Anne Chiang, MD, PhD; Megan E. Daly, MD; Carl M. Gay, MD, PhD; Jacob Sands,…

---

Working Group™: Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

Karen M. Winkfield, MD, PhD; Narjust Florez, MD, FASCO; Gilberto de Lima Lo…

---

Top 10 Oncogenic Drivers in NSCLC for 2024: Where Are We and Where Are We Going?

Melissa Johnson, MD; Dara Aisner, MD, PhD; David R. Gandara, MD; Balazs Hal…

---

Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?

Edward S. Kim, MD, MBA; Leah M. Backhus MD, MPH, FACS; Lyudmila A. Bazhenov…

---

BURST CME™: Illuminating the Crossroads of Precision Medicine and Targeted Treatment Options in Metastatic CRC

Tanios Bekaii-Saab, MD, FACP

---

BURST CME™: How Are Emerging Biomarkers and Testing Methodologies Shaping Personalized Medicine in NSCLC?

Ignacio I. Wistuba, MD

---

Revolutionizing Early-Stage NSCLC Treatment: Pathologists’ Key Insights Into Predicting Pathologic Responses to Immunotherapies

Melissa Johnson, MD; Edward Garon, MD, MS; Solange Peters, MD, PhD; Ignacio…

---

Community Practice Connections™: Pre-Conference Workshop on Immune Cell-Based Therapy

Andre H. Goy, MD; Marco L. Davila, MD, PhD; Ajay K. Nooka, MD, MPH, FACP

---

Community Practice Connections: 28th Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma

Jorge E. Cortes, MD; Ann LaCasce, MD, MMSc; Sagar Lonial, MD, FACP; Jennife…

---

Community Practice Connection™: How We Do It™: Defining HER2 Low on Your Pathology Reports to Make Informed Decisions in Breast Cancer Treatment

Komal Jhaveri, MD, FACP; Sunil S. Badve, MD, FRCPath; Paolo Tarantino, MD

---

Coffee Talk™: Navigating the Impact of HER2/3, TROP2, and PARP from Early Stage to Advanced Breast Cancer Care

Kevin Kalinsky, MD, MS; Komal Jhaveri, MD, FACP; Reshma L. Mahtani, DO; Kel…

---

2025 International Symposium of Gastrointestinal Oncology (ISGIO)

September 12-13, 2025

---